Intermittent hypoxia, the hallmark of OSA, causes dyslipidemia in mice by up-regulating hepatic lipid biosynthesis and lipoprotein secretion via hypoxia inducible factor 1 alpha [9], [10]. Here, HIF1A is linked to metabolic syndrome.